Xinhui Wu

1.0k total citations
41 papers, 613 citations indexed

About

Xinhui Wu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Xinhui Wu has authored 41 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Xinhui Wu's work include Neonatal Respiratory Health Research (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Xinhui Wu is often cited by papers focused on Neonatal Respiratory Health Research (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Xinhui Wu collaborates with scholars based in China, Netherlands and United States. Xinhui Wu's co-authors include E. Sacher, Michel Meunier, Reinoud Gosens, Mélanie Königshoff, Loes Kistemaker, John-Poul Ng-Blichfeldt, I. Sophie T. Bos, Pieter S. Hiemstra, Pascal Boireau and Tristan V. de Jong and has published in prestigious journals such as Journal of Applied Physics, Environmental Pollution and Science Advances.

In The Last Decade

Xinhui Wu

40 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinhui Wu China 16 198 155 107 73 66 41 613
Keitaro Morishita Japan 18 250 1.3× 123 0.8× 131 1.2× 141 1.9× 29 0.4× 73 811
Thomas Forest United States 11 80 0.4× 131 0.8× 42 0.4× 47 0.6× 13 0.2× 21 432
Gaurav Gupta India 14 125 0.6× 104 0.7× 159 1.5× 141 1.9× 56 0.8× 57 696
Camila F. Oliveira Brazil 13 65 0.3× 76 0.5× 34 0.3× 37 0.5× 59 0.9× 23 608
Tomohiro Tsuchiya Japan 18 107 0.5× 298 1.9× 287 2.7× 46 0.6× 46 0.7× 74 1.1k
Qingfeng Cao China 18 132 0.7× 535 3.5× 88 0.8× 73 1.0× 77 1.2× 81 1.4k
Ximena M. Bustamante-Marin United States 12 390 2.0× 323 2.1× 79 0.7× 45 0.6× 41 0.6× 19 886
Shigeo Ikeda Japan 17 94 0.5× 115 0.7× 109 1.0× 58 0.8× 18 0.3× 56 760
C. Robert Bagnell United States 16 70 0.4× 200 1.3× 59 0.6× 68 0.9× 31 0.5× 25 762

Countries citing papers authored by Xinhui Wu

Since Specialization
Citations

This map shows the geographic impact of Xinhui Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinhui Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinhui Wu more than expected).

Fields of papers citing papers by Xinhui Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinhui Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinhui Wu. The network helps show where Xinhui Wu may publish in the future.

Co-authorship network of co-authors of Xinhui Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xinhui Wu. A scholar is included among the top collaborators of Xinhui Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinhui Wu. Xinhui Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Xiaoqing, et al.. (2025). Targeting the immunometabolism interface: A novel strategy for IPF therapy. Pulmonary Pharmacology & Therapeutics. 91. 102394–102394. 1 indexed citations
2.
Zhou, Yexin, et al.. (2024). CAR-T cell therapy for hepatocellular carcinoma: current trends and challenges. Frontiers in Immunology. 15. 1489649–1489649. 15 indexed citations
3.
Wu, Wenjuan, et al.. (2023). Genetic association of telomere length, obesity and tobacoo smoking with idiopathic pulmonary fibrosis risk. BMC Public Health. 23(1). 868–868. 9 indexed citations
4.
Wu, Xinhui, et al.. (2023). Pericytes: The lung-forgotten cell type. Frontiers in Physiology. 14. 1150028–1150028. 18 indexed citations
5.
Xu, Cheng, Xinhui Wu, Fangying Lu, et al.. (2023). EGFL6 promotes bone metastasis of lung adenocarcinoma by increasing cancer cell malignancy and bone resorption. Clinical & Experimental Metastasis. 40(4). 357–371. 6 indexed citations
6.
Hu, Xiao, et al.. (2023). Iodine-Doped 3D Print Ti Alloy for Antibacterial Therapy on Orthopedic Implants. ACS Omega. 8(36). 32990–32997. 5 indexed citations
7.
Wu, Xinhui, I. Sophie T. Bos, René Wardenaar, et al.. (2022). Diesel exhaust particles distort lung epithelial progenitors and their fibroblast niche. Environmental Pollution. 305. 119292–119292. 28 indexed citations
8.
Wu, Xinhui, I. Sophie T. Bos, Thomas M. Conlon, et al.. (2022). A transcriptomics-guided drug target discovery strategy identifies receptor ligands for lung regeneration. Science Advances. 8(12). eabj9949–eabj9949. 30 indexed citations
9.
Zhang, Weikang, Yuhang Gong, Ting Jiang, et al.. (2022). VX-11e protects articular cartilage and subchondral bone in osteoarthritis by inhibiting the RIP1/RIP3/MLKL and MAPK signaling pathways. Bioorganic Chemistry. 120. 105632–105632. 9 indexed citations
10.
11.
Zhang, Weikang, Yuhang Gong, Jianxin Qiu, et al.. (2022). Platelet-Derived Growth Factor-BB Inhibits Intervertebral Disc Degeneration via Suppressing Pyroptosis and Activating the MAPK Signaling Pathway. Frontiers in Pharmacology. 12. 799130–799130. 19 indexed citations
12.
Pouwels, Simon D., Laura Hesse, Xinhui Wu, et al.. (2021). LL-37 and HMGB1 induce alveolar damage and reduce lung tissue regeneration via RAGE. American Journal of Physiology-Lung Cellular and Molecular Physiology. 321(4). L641–L652. 17 indexed citations
13.
Khedoe, Padmini P. S. J., Xinhui Wu, Reinoud Gosens, & Pieter S. Hiemstra. (2021). Repairing damaged lungs using regenerative therapy. Current Opinion in Pharmacology. 59. 85–94. 11 indexed citations
14.
Wu, Xinhui, John-Poul Ng-Blichfeldt, Ana Catarina Matias, et al.. (2021). Rho-Kinase 1/2 Inhibition Prevents Transforming Growth Factor-β-Induced Effects on Pulmonary Remodeling and Repair. Frontiers in Pharmacology. 11. 609509–609509. 16 indexed citations
15.
Wu, Xinhui, et al.. (2021). Inhibition of Lipopolysaccharide-Induced Inflammatory Bone Loss by Saikosaponin D is Associated with Regulation of the RANKL/RANK Pathway. Drug Design Development and Therapy. Volume 15. 4741–4757. 19 indexed citations
16.
Ng-Blichfeldt, John-Poul, Tristan V. de Jong, Xinhui Wu, et al.. (2019). TGF-β activation impairs fibroblast ability to support adult lung epithelial progenitor cell organoid formation. American Journal of Physiology-Lung Cellular and Molecular Physiology. 317(1). L14–L28. 59 indexed citations
17.
Wu, Xinhui, et al.. (2019). Mouse Lung Tissue Slice Culture. Methods in molecular biology. 1940. 297–311. 15 indexed citations
18.
Gao, Yan, Liqun Zhang, Yonghong Zhang, et al.. (2014). The Effects of Demecolcine, Alone or in Combination with Sucrose on Bovine Oocyte Protrusion Rate, MAPK1 Protein Level andC-MosGene Expression Level. Cellular Physiology and Biochemistry. 34(6). 1974–1982. 3 indexed citations
19.
Wang, Xu, Lei Chu, Benjamin M. Rosenthal, et al.. (2013). An anti-tumor protein produced by Trichinella spiralis induces apoptosis in human hepatoma H7402 cells. Veterinary Parasitology. 194(2-4). 186–188. 25 indexed citations
20.
Li, Chi‐Yuan, et al.. (2007). Identification of stage-specifically expressed genes ofTrichinella spiralisby suppression subtractive hybridization. Parasitology. 134(10). 1443–1455. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026